Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

By Michael Erman (Reuters) -Bristol Myers Squibb reported better-than-expected first-quarter revenue on Thursday and raised ...

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...

The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy Again" platform ...

Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their ...

Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.